Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853042 · ClinicalTrials.gov registry record
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
A clinical trial of Acute Coronary Syndrome and Acute Myocardial Infarction, sponsored by Hennepin Healthcare Research Institute.
- Active
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT05853042 is a study of Acute Coronary Syndrome and Acute Myocardial Infarction that is active but no longer recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 1,500 participants, below the 2,684-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05853042, a study of Acute Coronary Syndrome and Acute Myocardial Infarction, is active but no longer recruiting, sponsored by Hennepin Healthcare Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mindray High Sensitivity Troponin-I Measurement System is an in vitro diagnostic test for the quantitative determination of high sensitivity cardiac troponin I (hs-cTnI) in human serum or plasma. The Mindray High Sensitivity Troponin-I Measurement System is to be used as an aid in the diagnosis and rule out of acute myocardial infarction (AMI).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST high-sensitivity cardiac troponin testing
Study Locations (1)
Minnesota
- Hennepin Healthcare Research Institute / Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2025-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05853042
The ClinicalTrials.gov registry entry for NCT05853042 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,684-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (44% lower). The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which high-sensitivity cardiac troponin testing is the first listed.
NCT05853042 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05853042 about?
NCT05853042 is a clinical study titled "MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.". The Mindray High Sensitivity Troponin-I Measurement System is an in vitro diagnostic test for the quantitative determination of high sensitivity cardiac troponin I (hs-cTnI) in human serum or plasma. The Mindray High Sensitivity Troponin-I Measurement System is to be used as an aid in the diagnosis...
What is the current status of trial NCT05853042?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2022-12-12. Estimated completion is 2025-05-15.
What conditions does trial NCT05853042 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Acute Myocardial Infarction.
What interventions are being tested in trial NCT05853042?
The interventions under investigation include: high-sensitivity cardiac troponin testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05853042?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05853042 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.